eLife (Apr 2021)

Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses

  • Stephan Wilmes,
  • Polly-Anne Jeffrey,
  • Jonathan Martinez-Fabregas,
  • Maximillian Hafer,
  • Paul K Fyfe,
  • Elizabeth Pohler,
  • Silvia Gaggero,
  • Martín López-García,
  • Grant Lythe,
  • Charles Taylor,
  • Thomas Guerrier,
  • David Launay,
  • Suman Mitra,
  • Jacob Piehler,
  • Carmen Molina-París,
  • Ignacio Moraga

DOI
https://doi.org/10.7554/eLife.66014
Journal volume & issue
Vol. 10

Abstract

Read online

Cytokines elicit pleiotropic and non-redundant activities despite strong overlap in their usage of receptors, JAKs and STATs molecules. We use IL-6 and IL-27 to ask how two cytokines activating the same signaling pathway have different biological roles. We found that IL-27 induces more sustained STAT1 phosphorylation than IL-6, with the two cytokines inducing comparable levels of STAT3 phosphorylation. Mathematical and statistical modeling of IL-6 and IL-27 signaling identified STAT3 binding to GP130, and STAT1 binding to IL-27Rα, as the main dynamical processes contributing to sustained pSTAT1 levels by IL-27. Mutation of Tyr613 on IL-27Rα decreased IL-27-induced STAT1 phosphorylation by 80% but had limited effect on STAT3 phosphorgylation. Strong receptor/STAT coupling by IL-27 initiated a unique gene expression program, which required sustained STAT1 phosphorylation and IRF1 expression and was enriched in classical Interferon Stimulated Genes. Interestingly, the STAT/receptor coupling exhibited by IL-6/IL-27 was altered in patients with systemic lupus erythematosus (SLE). IL-6/IL-27 induced a more potent STAT1 activation in SLE patients than in healthy controls, which correlated with higher STAT1 expression in these patients. Partial inhibition of JAK activation by sub-saturating doses of Tofacitinib specifically lowered the levels of STAT1 activation by IL-6. Our data show that receptor and STATs concentrations critically contribute to shape cytokine responses and generate functional pleiotropy in health and disease.

Keywords